Document is current
Any future updates will be listed below
-
Authors
Zawada, Dorota https://orcid.org/0000-0003-1127-7980
Kornherr, Jessica
Meier, Anna B.
Santamaria, Gianluca https://orcid.org/0000-0001-9284-7492
Dorn, Tatjana
Nowak-Imialek, Monika
Ortmann, Daniel
Zhang, Fangfang
Lachmann, Mark
Dreßen, Martina https://orcid.org/0000-0003-2200-6254
Ortiz, Mariaestela
Mascetti, Victoria L.
Harmer, Stephen C. https://orcid.org/0000-0003-3909-6698
Nobles, Muriel
Tinker, Andrew https://orcid.org/0000-0001-7703-4151
De Angelis, Maria Teresa
Pedersen, Roger A.
Grote, Phillip https://orcid.org/0000-0002-9254-1458
Laugwitz, Karl-Ludwig https://orcid.org/0000-0003-4948-4846
Moretti, Alessandra https://orcid.org/0000-0001-5782-7832
Goedel, Alexander https://orcid.org/0000-0002-5980-2257
- License Information
-
More Information
Article History
Received: 2 June 2022
Accepted: 15 February 2023
First Online: 3 April 2023
Competing interests
: D.O. is currently an employee at Bit Bio Ltd. (United Kingdom) and holds stock options. R.A.P. is an advisor at Meatable NV (Netherlands) and holds stock options, is co-founder of DefiniGen Ltd. (United Kingdom) and holds shares, and is an advisor at Bit Bio Ltd. (United Kingdom) and holds stock options. A.G. receives consultancy fees from SmartCella (Sweden). The remaining authors declare that they have no competing interests.
